EXEL - Exelixis, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,611,062
1,611,062
1,434,970
987,538
967,775
Cost of revenue
57,909
57,909
52,873
36,272
33,097
Gross profit
1,553,153
1,553,153
1,382,097
951,266
934,678
Operating expenses
Research development
891,813
891,813
693,716
547,851
336,964
Selling general and administrative
459,856
459,856
401,715
293,355
228,244
Total operating expenses
1,351,669
1,351,669
1,095,431
841,206
565,208
Operating income or loss
201,484
201,484
286,666
110,060
369,470
Interest expense
0
-
-
-
0
Total other income/expenses net
-197
-197
-184
912
680
Income before tax
234,352
234,352
294,154
130,837
398,109
Income tax expense
52,070
52,070
63,091
19,056
77,097
Income from continuing operations
182,282
182,282
231,063
111,781
321,012
Net income
182,282
182,282
231,063
111,781
321,012
Net income available to common shareholders
182,282
182,282
231,063
111,781
321,012
Basic EPS
-
0.57
0.73
0.36
1.06
Diluted EPS
-
0.56
0.72
0.35
1.02
Basic average shares
-
321,526
314,884
308,271
302,584
Diluted average shares
-
324,556
322,359
318,001
315,009
EBITDA
-
201,484
286,666
110,060
369,470